These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28286577)

  • 1. In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201).
    Diao X; Carlier J; Zhu M; Pang S; Kronstrand R; Scheidweiler KB; Huestis MA
    Forensic Toxicol; 2017 Jan; 35(1):20-32. PubMed ID: 28286577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro and In Vivo Human Metabolism of Synthetic Cannabinoids FDU-PB-22 and FUB-PB-22.
    Diao X; Scheidweiler KB; Wohlfarth A; Pang S; Kronstrand R; Huestis MA
    AAPS J; 2016 Mar; 18(2):455-64. PubMed ID: 26810398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
    Yeter O; Ozturk YE
    Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of metabolites of the new synthetic cannabinoid CUMYL-4CN-BINACA in authentic urine samples and human liver microsomes using high-resolution mass spectrometry.
    Öztürk YE; Yeter O; Öztürk S; Karakus G; Ates I; Buyuk Y; Yurdun T
    Drug Test Anal; 2018 Mar; 10(3):449-459. PubMed ID: 28691766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection.
    Carlier J; Diao X; Huestis MA
    J Pharm Biomed Anal; 2018 Aug; 157():27-35. PubMed ID: 29754040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry.
    Wohlfarth A; Gandhi AS; Pang S; Zhu M; Scheidweiler KB; Huestis MA
    Anal Bioanal Chem; 2014 Feb; 406(6):1763-80. PubMed ID: 24518903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotransformation of the New Synthetic Cannabinoid with an Alkene, MDMB-4en-PINACA, by Human Hepatocytes, Human Liver Microsomes, and Human Urine and Blood.
    Watanabe S; Vikingsson S; Åstrand A; Gréen H; Kronstrand R
    AAPS J; 2019 Dec; 22(1):13. PubMed ID: 31848852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic profiling of synthetic cannabinoid 5F-ADB and identification of metabolites in authentic human blood samples via human liver microsome incubation and ultra-high-performance liquid chromatography/high-resolution mass spectrometry.
    Presley BC; Castaneto MS; Logan BK; Jansen-Varnum SA
    Rapid Commun Mass Spectrom; 2020 Nov; 34(22):e8908. PubMed ID: 32710798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA.
    Wohlfarth A; Castaneto MS; Zhu M; Pang S; Scheidweiler KB; Kronstrand R; Huestis MA
    AAPS J; 2015 May; 17(3):660-77. PubMed ID: 25721194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic profiling of new synthetic cannabinoids AMB and 5F-AMB by human hepatocyte and liver microsome incubations and high-resolution mass spectrometry.
    Andersson M; Diao X; Wohlfarth A; Scheidweiler KB; Huestis MA
    Rapid Commun Mass Spectrom; 2016 Apr; 30(8):1067-78. PubMed ID: 27003044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Looking at flubromazolam metabolism from four different angles: Metabolite profiling in human liver microsomes, human hepatocytes, mice and authentic human urine samples with liquid chromatography high-resolution mass spectrometry.
    Wohlfarth A; Vikingsson S; Roman M; Andersson M; Kugelberg FC; Green H; Kronstrand R
    Forensic Sci Int; 2017 May; 274():55-63. PubMed ID: 27863836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic In Vitro Metabolic Profiling of the OXIZID Synthetic Cannabinoids BZO-4en-POXIZID, BZO-POXIZID, 5F-BZO-POXIZID, BZO-HEXOXIZID and BZO-CHMOXIZID.
    Watanabe S; Baginski S; Iwai T; Matsushita R; Takatsu M; Nakanishi T; Lindbom K; Mckenzie C; Vikingsson S; Kronstrand R; Gréen H; Seto Y
    J Anal Toxicol; 2023 May; 47(5):455-463. PubMed ID: 36857377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolite Profiling of Ortho-, Meta- and Para-Fluorofentanyl by Hepatocytes and High-Resolution Mass Spectrometry.
    Gundersen POM; Åstrand A; Gréen H; Josefsson M; Spigset O; Vikingsson S
    J Anal Toxicol; 2020 Mar; 44(2):140-148. PubMed ID: 31788682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Resolution Mass Spectrometry for Characterizing the Metabolism of Synthetic Cannabinoid THJ-018 and Its 5-Fluoro Analog THJ-2201 after Incubation in Human Hepatocytes.
    Diao X; Wohlfarth A; Pang S; Scheidweiler KB; Huestis MA
    Clin Chem; 2016 Jan; 62(1):157-69. PubMed ID: 26430074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Phase I Metabolism of the Recently Emerged Synthetic MDMB-4en-PINACA and Its Detection in Human Urine Samples.
    Erol Ozturk Y; Yeter O
    J Anal Toxicol; 2021 Jan; 44(9):976-984. PubMed ID: 32091101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation.
    Wohlfarth A; Scheidweiler KB; Pang S; Zhu M; Castaneto M; Kronstrand R; Huestis MA
    Drug Test Anal; 2016 Aug; 8(8):779-91. PubMed ID: 26331297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes.
    Gandhi AS; Wohlfarth A; Zhu M; Pang S; Castaneto M; Scheidweiler KB; Huestis MA
    Drug Test Anal; 2015 Mar; 7(3):187-98. PubMed ID: 24827428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
    Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5F-MDMB-PICA metabolite identification and cannabinoid receptor activity.
    Truver MT; Watanabe S; Åstrand A; Vikingsson S; Green H; Swortwood MJ; Kronstrand R
    Drug Test Anal; 2020 Jan; 12(1):127-135. PubMed ID: 31461219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive quantification of BB-22 and its metabolite BB-22 3-carboxyindole, and characterization of new metabolites in authentic urine and/or serum specimens obtained from three individuals by LC-QTRAP-MS/MS and high-resolution LC-Orbitrap-MS/MS.
    Minakata K; Hasegawa K; Nozawa H; Yamagishi I; Saitoh T; Yoshino A; Suzuki M; Kitamoto T; Suzuki O; Watanabe K
    Forensic Toxicol; 2019; 37(1):164-173. PubMed ID: 30636985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.